Quest Diagnostics Inc. Stock
Quest Diagnostics Inc. Stock
A loss of -1.410% shows a downward development for Quest Diagnostics Inc..
Quest Diagnostics Inc. is currently one of the favorites of our community with 12 Buy predictions and no Sell predictions.
As a result the target price of 173 € shows a slightly positive potential of 11.97% compared to the current price of 154.5 € for Quest Diagnostics Inc..
Pros and Cons of Quest Diagnostics Inc. in the next few years
Pros
?
B****
?
G***** c******* t* c**********
?
M***** P*******
Cons
?
W********* I********* f** t** n*** y****
?
S********** s********
?
C******** o* t** e**********
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Quest Diagnostics Inc. vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Quest Diagnostics Inc. | -1.410% | -1.592% | -0.451% | 3.000% | 6.625% | 9.326% | 50.000% |
| Anthem Inc. | -0.530% | -0.351% | 3.239% | -24.367% | -19.449% | -43.089% | 7.625% |
| HCA Holdings Inc. | -0.550% | -2.347% | 1.941% | 39.231% | 46.309% | 86.218% | 217.228% |
| Universal Health Services B | -2.510% | -5.340% | -1.515% | 6.557% | 14.035% | 58.821% | 77.273% |
Comments
Quest Diagnostics (NYSE:DGX) had its "outperform" rating reaffirmed by analysts at Leerink Partners.
Show more
Ratings data for DGX provided by MarketBeat
Quest Diagnostics (NYSE:DGX) had its "buy" rating reaffirmed by analysts at Jefferies Financial Group Inc..
Show more
Ratings data for DGX provided by MarketBeat
Quest Diagnostics Incorporated (NYSE: DGX) had its "outperform" rating re-affirmed by analysts at William Blair.
Show more
Ratings data for DGX provided by MarketBeat